Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Aneurysm Clip Market

ID: MRFR/HC/27187-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
Aneurysm Clip Market Research Report: Size, Share, Trend Analysis By Aneurysm Type (Saccular Aneurysms, Fusiform Aneurysms, Dissecting Aneurysms), By Endovascular Approach (Endoscopic Coiling, Stenting, Flow-Diverting Stents, Aneurysm Clip), By Clip Type (Non-Fenestrated Clips, Fenestrated Clips, Asymmetric Clips, Bifurcated Clips, Pipeline Embolization Device), By Material (Titanium, Nitinol, Stainless Steel, Polymer), By Applications (Intracranial Aneurysms, Extracranial Aneurysms, Carotid Aneurysms, Vertebral Aneurysms, Basilar Aneurysms) and By Regional - Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Aneurysm Type (USD Billion)
      1. 4.1.1 Saccular Aneurysms
      2. 4.1.2 Fusiform Aneurysms
      3. 4.1.3 Dissecting Aneurysms
    2. 4.2 Healthcare, BY Endovascular Approach (USD Billion)
      1. 4.2.1 Endoscopic Coiling
      2. 4.2.2 Stenting
      3. 4.2.3 Flow-Diverting Stents
    3. 4.3 Healthcare, BY Clip Type (USD Billion)
      1. 4.3.1 Non-Fenestrated Clips
      2. 4.3.2 Fenestrated Clips
      3. 4.3.3 Asymmetric Clips
      4. 4.3.4 Bifurcated Clips
      5. 4.3.5 Pipeline Embolization Device
    4. 4.4 Healthcare, BY Material (USD Billion)
      1. 4.4.1 Titanium
      2. 4.4.2 Nitinol
      3. 4.4.3 Stainless Steel
      4. 4.4.4 Polymer
    5. 4.5 Healthcare, BY Application (USD Billion)
      1. 4.5.1 Intracranial Aneurysms
      2. 4.5.2 Extracranial Aneurysms
      3. 4.5.3 Carotid Aneurysms
      4. 4.5.4 Vertebral Aneurysms
      5. 4.5.5 Basilar Aneurysms
    6. 4.6 Healthcare, BY Region (USD Billion)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Stryker (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Terumo Corporation (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 B. Braun Melsungen AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cook Medical (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 MicroVention (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY ANEURYSM TYPE
    4. 6.4 US MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    5. 6.5 US MARKET ANALYSIS BY CLIP TYPE
    6. 6.6 US MARKET ANALYSIS BY MATERIAL
    7. 6.7 US MARKET ANALYSIS BY APPLICATION
    8. 6.8 CANADA MARKET ANALYSIS BY ANEURYSM TYPE
    9. 6.9 CANADA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    10. 6.10 CANADA MARKET ANALYSIS BY CLIP TYPE
    11. 6.11 CANADA MARKET ANALYSIS BY MATERIAL
    12. 6.12 CANADA MARKET ANALYSIS BY APPLICATION
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY ANEURYSM TYPE
    15. 6.15 GERMANY MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    16. 6.16 GERMANY MARKET ANALYSIS BY CLIP TYPE
    17. 6.17 GERMANY MARKET ANALYSIS BY MATERIAL
    18. 6.18 GERMANY MARKET ANALYSIS BY APPLICATION
    19. 6.19 UK MARKET ANALYSIS BY ANEURYSM TYPE
    20. 6.20 UK MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    21. 6.21 UK MARKET ANALYSIS BY CLIP TYPE
    22. 6.22 UK MARKET ANALYSIS BY MATERIAL
    23. 6.23 UK MARKET ANALYSIS BY APPLICATION
    24. 6.24 FRANCE MARKET ANALYSIS BY ANEURYSM TYPE
    25. 6.25 FRANCE MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    26. 6.26 FRANCE MARKET ANALYSIS BY CLIP TYPE
    27. 6.27 FRANCE MARKET ANALYSIS BY MATERIAL
    28. 6.28 FRANCE MARKET ANALYSIS BY APPLICATION
    29. 6.29 RUSSIA MARKET ANALYSIS BY ANEURYSM TYPE
    30. 6.30 RUSSIA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    31. 6.31 RUSSIA MARKET ANALYSIS BY CLIP TYPE
    32. 6.32 RUSSIA MARKET ANALYSIS BY MATERIAL
    33. 6.33 RUSSIA MARKET ANALYSIS BY APPLICATION
    34. 6.34 ITALY MARKET ANALYSIS BY ANEURYSM TYPE
    35. 6.35 ITALY MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    36. 6.36 ITALY MARKET ANALYSIS BY CLIP TYPE
    37. 6.37 ITALY MARKET ANALYSIS BY MATERIAL
    38. 6.38 ITALY MARKET ANALYSIS BY APPLICATION
    39. 6.39 SPAIN MARKET ANALYSIS BY ANEURYSM TYPE
    40. 6.40 SPAIN MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    41. 6.41 SPAIN MARKET ANALYSIS BY CLIP TYPE
    42. 6.42 SPAIN MARKET ANALYSIS BY MATERIAL
    43. 6.43 SPAIN MARKET ANALYSIS BY APPLICATION
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY ANEURYSM TYPE
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY CLIP TYPE
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY ANEURYSM TYPE
    51. 6.51 CHINA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    52. 6.52 CHINA MARKET ANALYSIS BY CLIP TYPE
    53. 6.53 CHINA MARKET ANALYSIS BY MATERIAL
    54. 6.54 CHINA MARKET ANALYSIS BY APPLICATION
    55. 6.55 INDIA MARKET ANALYSIS BY ANEURYSM TYPE
    56. 6.56 INDIA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    57. 6.57 INDIA MARKET ANALYSIS BY CLIP TYPE
    58. 6.58 INDIA MARKET ANALYSIS BY MATERIAL
    59. 6.59 INDIA MARKET ANALYSIS BY APPLICATION
    60. 6.60 JAPAN MARKET ANALYSIS BY ANEURYSM TYPE
    61. 6.61 JAPAN MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    62. 6.62 JAPAN MARKET ANALYSIS BY CLIP TYPE
    63. 6.63 JAPAN MARKET ANALYSIS BY MATERIAL
    64. 6.64 JAPAN MARKET ANALYSIS BY APPLICATION
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY ANEURYSM TYPE
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY CLIP TYPE
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    70. 6.70 MALAYSIA MARKET ANALYSIS BY ANEURYSM TYPE
    71. 6.71 MALAYSIA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    72. 6.72 MALAYSIA MARKET ANALYSIS BY CLIP TYPE
    73. 6.73 MALAYSIA MARKET ANALYSIS BY MATERIAL
    74. 6.74 MALAYSIA MARKET ANALYSIS BY APPLICATION
    75. 6.75 THAILAND MARKET ANALYSIS BY ANEURYSM TYPE
    76. 6.76 THAILAND MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    77. 6.77 THAILAND MARKET ANALYSIS BY CLIP TYPE
    78. 6.78 THAILAND MARKET ANALYSIS BY MATERIAL
    79. 6.79 THAILAND MARKET ANALYSIS BY APPLICATION
    80. 6.80 INDONESIA MARKET ANALYSIS BY ANEURYSM TYPE
    81. 6.81 INDONESIA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    82. 6.82 INDONESIA MARKET ANALYSIS BY CLIP TYPE
    83. 6.83 INDONESIA MARKET ANALYSIS BY MATERIAL
    84. 6.84 INDONESIA MARKET ANALYSIS BY APPLICATION
    85. 6.85 REST OF APAC MARKET ANALYSIS BY ANEURYSM TYPE
    86. 6.86 REST OF APAC MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    87. 6.87 REST OF APAC MARKET ANALYSIS BY CLIP TYPE
    88. 6.88 REST OF APAC MARKET ANALYSIS BY MATERIAL
    89. 6.89 REST OF APAC MARKET ANALYSIS BY APPLICATION
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY ANEURYSM TYPE
    92. 6.92 BRAZIL MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    93. 6.93 BRAZIL MARKET ANALYSIS BY CLIP TYPE
    94. 6.94 BRAZIL MARKET ANALYSIS BY MATERIAL
    95. 6.95 BRAZIL MARKET ANALYSIS BY APPLICATION
    96. 6.96 MEXICO MARKET ANALYSIS BY ANEURYSM TYPE
    97. 6.97 MEXICO MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    98. 6.98 MEXICO MARKET ANALYSIS BY CLIP TYPE
    99. 6.99 MEXICO MARKET ANALYSIS BY MATERIAL
    100. 6.100 MEXICO MARKET ANALYSIS BY APPLICATION
    101. 6.101 ARGENTINA MARKET ANALYSIS BY ANEURYSM TYPE
    102. 6.102 ARGENTINA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    103. 6.103 ARGENTINA MARKET ANALYSIS BY CLIP TYPE
    104. 6.104 ARGENTINA MARKET ANALYSIS BY MATERIAL
    105. 6.105 ARGENTINA MARKET ANALYSIS BY APPLICATION
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANEURYSM TYPE
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLIP TYPE
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY ANEURYSM TYPE
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY CLIP TYPE
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY ANEURYSM TYPE
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY CLIP TYPE
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    122. 6.122 REST OF MEA MARKET ANALYSIS BY ANEURYSM TYPE
    123. 6.123 REST OF MEA MARKET ANALYSIS BY ENDOVASCULAR APPROACH
    124. 6.124 REST OF MEA MARKET ANALYSIS BY CLIP TYPE
    125. 6.125 REST OF MEA MARKET ANALYSIS BY MATERIAL
    126. 6.126 REST OF MEA MARKET ANALYSIS BY APPLICATION
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY ANEURYSM TYPE, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY ANEURYSM TYPE, 2024 TO 2035 (USD Billion)
    135. 6.135 HEALTHCARE, BY ENDOVASCULAR APPROACH, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY ENDOVASCULAR APPROACH, 2024 TO 2035 (USD Billion)
    137. 6.137 HEALTHCARE, BY CLIP TYPE, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY CLIP TYPE, 2024 TO 2035 (USD Billion)
    139. 6.139 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
    141. 6.141 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.2.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.2.5 BY APPLICATION, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.3.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.3.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.3.5 BY APPLICATION, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.4.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.4.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.4.5 BY APPLICATION, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.5.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.5.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.5.5 BY APPLICATION, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.6.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.6.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.6.5 BY APPLICATION, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.7.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.7.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.7.5 BY APPLICATION, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.8.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.8.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.8.5 BY APPLICATION, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.9.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.9.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.9.5 BY APPLICATION, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.10.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.10.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.10.5 BY APPLICATION, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.11.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.11.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.11.5 BY APPLICATION, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.12.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.12.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.12.5 BY APPLICATION, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.13.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.13.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.13.5 BY APPLICATION, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.14.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.14.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.14.5 BY APPLICATION, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.15.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.15.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.15.5 BY APPLICATION, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.16.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.16.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.16.5 BY APPLICATION, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.17.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.17.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.17.5 BY APPLICATION, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.18.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.18.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.18.5 BY APPLICATION, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.19.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.19.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.19.5 BY APPLICATION, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.20.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.20.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.20.5 BY APPLICATION, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.21.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.21.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.21.5 BY APPLICATION, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.22.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.22.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.22.5 BY APPLICATION, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.23.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.23.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.23.5 BY APPLICATION, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.24.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.24.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.24.5 BY APPLICATION, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.25.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.25.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.25.5 BY APPLICATION, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.26.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.26.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.26.5 BY APPLICATION, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.27.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.27.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.27.5 BY APPLICATION, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.28.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.28.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.28.5 BY APPLICATION, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.29.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.29.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.29.5 BY APPLICATION, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY ANEURYSM TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY ENDOVASCULAR APPROACH, 2025-2035 (USD Billion)
      3. 7.30.3 BY CLIP TYPE, 2025-2035 (USD Billion)
      4. 7.30.4 BY MATERIAL, 2025-2035 (USD Billion)
      5. 7.30.5 BY APPLICATION, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Aneurysm Type (USD Billion, 2025-2035)

  • Saccular Aneurysms
  • Fusiform Aneurysms
  • Dissecting Aneurysms

Healthcare By Endovascular Approach (USD Billion, 2025-2035)

  • Endoscopic Coiling
  • Stenting
  • Flow-Diverting Stents

Healthcare By Clip Type (USD Billion, 2025-2035)

  • Non-Fenestrated Clips
  • Fenestrated Clips
  • Asymmetric Clips
  • Bifurcated Clips
  • Pipeline Embolization Device

Healthcare By Material (USD Billion, 2025-2035)

  • Titanium
  • Nitinol
  • Stainless Steel
  • Polymer

Healthcare By Application (USD Billion, 2025-2035)

  • Intracranial Aneurysms
  • Extracranial Aneurysms
  • Carotid Aneurysms
  • Vertebral Aneurysms
  • Basilar Aneurysms